Skip to main content
. Author manuscript; available in PMC: 2020 Aug 9.
Published in final edited form as: Cancer Epidemiol. 2019 Dec 6;64:101649. doi: 10.1016/j.canep.2019.101649

Table 2:

Risk of SPMN according to the characteristics of the index cancer, stratified by sex, SEER 2000–2015.

Men Women


Observed SPMN SIR (95 % CI) EAR per 10000 PYR Observed SPMN SIR (95 % CI) EAR per 10000 PYR
Age at diagnosis of index malignancy, y
 < 49 424 2.65 (2.40, 2.91) 75.32 1,270 1.86 (1.76, 1.97) 31.96
 50–59 1,333 1.90 (1.80, 2.00) 100.86 1,149 1.86 (1.75, 1.97) 76.09
 60–69 1,312 1.58 (1.50, 1.67) 120.35 1,042 1.67 (1.57, 1.77) 93.82
 70+ 661 1.35 (1.25, 1.46) 101.70 1,031 1.56 (1.47, 1.66) 103.09
Race
 White 3,266 1.68 (1.62, 1.74) 96.04 3,577 1.69 (1.64, 1.75) 55.47
 Black 361 2.06 (1.86, 2.29) 169.34 634 2.10 (1.94, 2.27) 82.10
 Other 100 2.13 (1.74, 2.59) 104.48 277 1.82 (1.61, 2.04) 47.18
Marital status at diagnosis of index malignancy
 Married 2,276 1.61 (1.54, 1.67) 86.80 1,915 1.68 (1.61, 1.76) 48.80
 Divorced/separated/widowed 675 1.84 (1.71, 1.99) 130.36 1,430 1.73 (1.65, 1.83) 79.58
 Never married 605 2.08 (1.92, 2.26) 129.68 873 1.90 (1.77, 2.03) 52.45
 Unknown 174 1.62 (1.39, 1.88) 87.43 274 1.72 (1.53, 1.94) 55.79
Year of diagnosis of index malignancy
 2000–2004 1,440 1.65 (1.57, 1.74) 96.26 2,002 1.52 (1.45, 1.58) 40.10
 2005–2009 1,400 1.72 (1.63, 1.81) 98.76 1,589 1.86 (1.77, 1.95) 65.65
 2010+ 643 1.79 (1.65, 1.93) 106.36 651 2.25 (2.08, 2.43) 97.81
Grade of index malignancy
 Well 257 1.74 (1.53, 1.96) 122.26 603 1.89 (1.74, 2.05) 70.41
 Moderate 1,312 1.88 (1.78, 1.99) 121.86 1,545 1.90 (1.80, 2.00) 71.61
 Poor 1,363 1.59 (1.51, 1.68) 83.22 1,124 1.66 (1.56, 1.75) 53.68
 Undifferentiated/unknown 798 1.66 (1.54, 1.78) 92.87 1,214 1.58 (1.49, 1.67) 41.33
Stage of index malignancy
 Localized 695 1.74 (1.61, 1.87) 119.58 2,172 1.61 (1.55, 1.68) 42.46
 Regional 2,400 1.63 (1.57. 1.70) 86.41 1,846 1.85 (1.77, 1.94) 76.25
 Distant 512 2.12 (1.94, 2.31) 154.75 270 1.98 (1.75, 2.23) 86.35
 Unknown/unstaged 123 1.80 (1.50, 2.15) 111.74 202 1.95 (1.69, 2.24) 77.72

SPMN = Second primary malignant neoplasm; SEER = Surveillance, Epidemiology, and End Results; SIR = Standardized incidence ratio; EAR = Excess absolute risk; PYR = Person-year at risk; CI = Confidence interval; HPV = Human papillomavirus.